PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome
Authors
Keywords
-
Journal
World Journal of Surgical Oncology
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-23
DOI
10.1186/s12957-020-02082-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
- (2019) Chu-Yu Jing et al. Journal for ImmunoTherapy of Cancer
- The Tumor Microenvironment and Immune Milieu of Cholangiocarcinoma
- (2019) Luca Fabris et al. LIVER INTERNATIONAL
- Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery
- (2019) Luca Vigano et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Anti-PD-L1 treatment results in functional remodeling of the macrophage compartment
- (2019) Huizhong Xiong et al. CANCER RESEARCH
- Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade
- (2019) Minghao Sui et al. Journal for ImmunoTherapy of Cancer
- M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
- (2019) Lili Cao et al. Cancer Management and Research
- Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
- (2019) Xiaoliang Liu et al. Journal for ImmunoTherapy of Cancer
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
- (2018) Chao-Qun Liu et al. BRITISH JOURNAL OF CANCER
- Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
- (2018) Furong Liu et al. BULLETIN DU CANCER
- Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer
- (2018) Dan Tan et al. Cancer Biomarkers
- CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients
- (2018) Long-Zi Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
- (2018) Daniela S. Thommen et al. NATURE MEDICINE
- Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
- (2018) Genevieve P Hartley et al. Cancer Immunology Research
- Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages
- (2017) Canhua Jiang et al. IMMUNOBIOLOGY
- Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment
- (2017) Mark A. J. Gorris et al. JOURNAL OF IMMUNOLOGY
- Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
- (2017) Le Ying et al. Journal of Translational Medicine
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
- (2017) Ke Ma et al. Oncology Letters
- Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2017) Hae Il Jung et al. Cancer Research and Treatment
- A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma
- (2017) Bo-Hao Zheng et al. Clinical and Translational Gastroenterology
- Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
- (2017) Georgi Atanasov et al. OncoImmunology
- Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer
- (2017) Tao Shen et al. Scientific Reports
- Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma
- (2016) Faiz Gani et al. ANNALS OF SURGICAL ONCOLOGY
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway
- (2016) Long-Zi Liu et al. Oncotarget
- Novel immunotherapy in the treatment of advanced non-small cell lung cancer
- (2016) G. Santabarbara et al. Expert Review of Clinical Pharmacology
- Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition
- (2015) Liu-Xiao Yang et al. HEPATOLOGY
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Intrahepatic Cholangiocarcinoma: expert consensus statement
- (2015) Sharon M. Weber et al. HPB
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Macrophage density and macrophage colony-stimulating factor expression predict the postoperative prognosis in patients with intrahepatic cholangiocarcinoma
- (2014) Kosuke Oishi et al. SURGERY TODAY
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies
- (2013) Rebecca M. Dodson et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China
- (2008) Yan-Ming Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search